Skip to main content
NIH funding notice RFA-DA-14-003

Advancing Exceptional Research on HIV/AIDS (R01)

Closed on August 1, 2013.

Posted
March 20, 2013
Close date
August 1, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,318,999 in first-year total cost, median $659,500.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 NXR-B (09)]2

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
  2. ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS1
Competing awards under RFA-DA-14-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Threshold of Cognitive Impairment after HIV Infection: Effect of Morphine1R01DA037611-01VOLSKY, DAVID JST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS, NY$805,969ZDA1
2014Maximizing respect and improving outcomes in HIV and substance abuse (MaRIPOHSA)1R01DA037601-01BEACH, MARY CATHERINEJOHNS HOPKINS UNIVERSITY, MD$513,030ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.